Both in Pharmaceuticals
Spruce Biosciences vs Pyxis Oncology
Over the past year SPRB returned −59.1% and PYXS returned −57.0%; their daily moves had a correlation of 0.11.
SPRB −59.1% PYXS −57.0%Growth of $1, one year, split-adjusted
| Metric | SPRB | PYXS |
|---|---|---|
| Price | $42.81 | $1.64 |
| Market cap | $123.0M | $136.8M |
| Today | −3.91% | −2.96% |
| 1 month | −5.7% | −26.8% |
| 6 months | −27.9% | −10.4% |
| Year to date | −50.9% | +42.6% |
| 1 year | −61.1% | −53.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 12.4× |
| Net cash | $89.2M | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 112.4% |
| Short % of float | 22.4% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).